RT Journal Article
SR Electronic
T1 Double trouble? When a pandemic and seasonal virus collide
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.30.20047993
DO 10.1101/2020.03.30.20047993
A1 Casey Zipfel
A1 Vittoria Colizza
A1 Shweta Bansal
YR 2021
UL http://medrxiv.org/content/early/2021/01/12/2020.03.30.20047993.abstract
AB As healthcare capacities in the US and Europe reach their limits due to a surge in the COVID-19 pandemic, both regions enter the 2020-2021 influenza season. Southern hemisphere countries that had suppressed influenza seasons provide a hopeful example, but the lack of reduction in influenza in the 2019-2020 influenza season and heterogeneity in nonpharmaceutical and pharmaceutical interventions show that we cannot assume the same effect will occur globally. The US and Europe must promote the implementation and continuation of these measures in order to prevent additional burden to healthcare systems due to influenza.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank Reseau Sentinelles and IQVIA France for providing us access to flu vaccine sale data. Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R01GM123007. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We also acknowledge support from the PhRMA Foundation.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the study is publicly available and cited in the work https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html https://www.google.com/covid19/mobility/